[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368839-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368839-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","multi-omics-integration-uncovers-key-transcriptional-regulators-in-triple-negative-breast-cancer-spatial-heterogeneity","Multi-omics integration uncovers key transcriptional regulators in triple-negative breast cancer spatial heterogeneity","","Triple-negative breast cancer (TNBC) is an aggressive subtype lacking hormone receptors, which makes treatment difficult and drives substantial intratumor heterogeneity. A spatial multi-omics strategy combining single-cell RNA sequencing and spatial transcriptomics was used to build a spatial cell atlas and map cell-type-specific distributions. The study identifies cell-type and spatial heterogeneity, transcription factor regulatory networks, receptor-ligand interactions linked to tumor aggression, and shared enrichment pathways supporting cancer progression.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/multi-omics-integration-uncovers-key-transcriptional-regulators-in-triple-negative-breast-cancer-spatial-heterogeneity/368839/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/multi-omics-integration-uncovers-key-transcriptional-regulators-in-triple-negative-breast-cancer-spatial-heterogeneity/368839.png","ImageObject",300,407,{"name":42,"@type":43},"4398046744996","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does this research address in triple-negative breast cancer?","Question",{"text":63,"@type":64},"It addresses how TNBC’s lack of hormone receptors contributes to aggressive behavior and challenging treatment due to extensive spatial and intratumor heterogeneity.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which data types were combined in the methods?",{"text":68,"@type":64},"The study integrated single-cell RNA sequencing (scRNAseq) with spatial transcriptomics to generate a spatial cell atlas and map cell-type-specific distributions.",{"name":70,"@type":61,"acceptedAnswer":71},"What major regulators and signaling mechanisms were identified?",{"text":72,"@type":64},"Transcription factor networks highlighted epithelial regulators (e.g., TFF3, RARG, GRHL1, RORC, KLF5) and mesenchymal regulators (e.g., EMX2, TWIST1, TWIST2, NFATC4, HOXC6). Receptor-ligand analysis emphasized KNG1_BDKRB2 and NRG1_ERBB4 signaling as contributors to tumor aggression.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368839,1790413250,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":11,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":133,"file_id":134,"file_url":135,"file_type":136,"file_size":137,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":138,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":26,"preview_urls":145},4398046744996,"TYPE Original Research PUBLISHED 03 September 2025 DOI 10.3389/fgene.2025.1614254  \nOPEN ACCESS  \nEDITED BY  \nGhislain Bidaut,  \nAix Marseille Université, France  \nREVIEWED BY  \nNandita Joshi,  \nResearch Laboratories Merck, United States Enrique Ivan Ramos,  \nThe University of Texas at El Paso, United States  \n*CORRESPONDENCE  \nShou-Ping Gong,  \n [gongshouping@xiyi.edu.cn](gongshouping@xiyi.edu.cn)[ ](gongshouping@xiyi.edu.cn)Hui-Ling Cao,  \n [caohuiling_jzs@xiyi.edu.cn](caohuiling_jzs@xiyi.edu.cn)  \n†These authors have contributed equally to this work  \nRECEIVED 18 April 2025  \nACCEPTED 14 August 2025  \nPUBLISHED 03 September 2025  \nCORRECTED 26 September 2025  \nCITATION  \nZhang N, Zhang Y, Yang R-F, Tan M, Chu H-Q, Rehman A, Yang L-Y, Li Y-Y, Alshabrmi FM, Zhou X, Xu F, Gong S-P and Cao H-L (2025) Multi-omics integration uncovers key transcriptional regulators in triple-negative breast cancer spatial heterogeneity.  \nFront. Genet. 16:1614254 .  \ndoi: 10.3389/fgene.2025.1614254  \nCOPYRIGHT  \n© 2025 Zhang, Zhang, Yang, Tan, Chu, Rehman, Yang, Li, Alshabrmi, Zhou, Xu, Gong and Cao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nMulti-omics integration uncovers key transcriptional regulators in triple-negative breast cancer spatial heterogeneity  \nNing Zhang 1,2,3†, Ye Zhang 1†, Rui-Fei Yang 1†, Min Tan 4,  \nHai-Qing Chu 1, Abdur Rehman 2, Lu-Yu Yang 2, Ya-Yu Li 2, Fahad M. Alshabrmi 5, Xin Zhou 1, Feili Xu 3, Shou-Ping Gong 1* and Hui-Ling Cao 1*  \n1Xi ’an Key Laboratory of Basic and Translation of Cardiovascular Metabolic Disease, Xi’an Key Laboratory of Autoimmune Rheumatic Disease, College of Pharmacy, Xi’an Medical University, Xi’an, China, 2College of Life Sciences, Northwest A&F University, Yangling, Shaanxi, China, 3College of Health Management, Shangluo University, Shangluo, Shaanxi, China, 4Xi’an Siyuan University, Xi’an, China, 5Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah, Saudi Arabia  \nBackground: Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer characterized by a lack of hormone receptors, making it challenging to treat.  \nMethods: We generated a comprehensive spatial cell atlas ofTNBC using a multiomics integration approach that combined single-cell RNA sequencing (scRNAseq) with spatial transcriptomics. This integration allowed us to characterize the spatial microenvironment and map the cell-type-speciﬁc distributions in TNBC tissues.  \nResults: Our analysis revealed signiﬁcant heterogeneity in cell types and spatial distribution, with normal regions enriched in insulin resistance functions, whereas cancerous regions displayed diverse cell populations, including immune cells, cancer-associated ﬁbroblasts (CAFs), and mesenchymal cells. By constructing transcription factor (TF) regulatory networks, we identiﬁed TFF3, RARG, GRHL1, RORC, and KLF5 as critical regulators of epithelial cells, whereas EMX2, TWIST1, TWIST2, NFATC4, and HOXC6 were found to play essential roles in mesenchymal cells. Immunohistochemical validation supported the involvement of these TFs in TNBC. Further analysis of receptor-ligand interactions highlighted the roles of KNG1 _BDKRB2 and NRG1 _ERBB4 signaling in promoting tumor aggression, suggesting potential therapeutic targets. GO enrichment analysis revealed overlapping pathways between epithelial and mesenchymal cells, focusing on migration, signaling, and development, indicating that the shared regulatory mechanisms contribute to cancer progression.  \nConclusion: Our ﬁndings provide new insights into the TN","cbCaivnTofE0wS33","https://ap.wps.com/l/cbCaivnTofE0wS33","pdf",5590577,13,"English","# Background\n# Methods\n# Results\n## Spatial heterogeneity and cell-type distributions\n## Transcription factor regulatory networks\n## Receptor-ligand interactions and pathway enrichment\n# Conclusion\n# Keywords\n# Introduction","[{\"question\":\"What problem does this research address in triple-negative breast cancer?\",\"answer\":\"It addresses how TNBC’s lack of hormone receptors contributes to aggressive behavior and challenging treatment due to extensive spatial and intratumor heterogeneity.\"},{\"question\":\"Which data types were combined in the methods?\",\"answer\":\"The study integrated single-cell RNA sequencing (scRNAseq) with spatial transcriptomics to generate a spatial cell atlas and map cell-type-specific distributions.\"},{\"question\":\"What major regulators and signaling mechanisms were identified?\",\"answer\":\"Transcription factor networks highlighted epithelial regulators (e.g., TFF3, RARG, GRHL1, RORC, KLF5) and mesenchymal regulators (e.g., EMX2, TWIST1, TWIST2, NFATC4, HOXC6). Receptor-ligand analysis emphasized KNG1_BDKRB2 and NRG1_ERBB4 signaling as contributors to tumor aggression.\"}]","Multi-omics integration uncovers key transcriptional regulators in triple-negative breast cancer spatial heterogeneity | PDF",1790178895,33,[146,150],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/25eb2c7074154a8a57e038537fe8589b.webp",983,1390,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-08/a511796f720bc1267adf6b525091a614.webp",982,1388]